MktsMarkets

Lexicon Pharmaceuticals, Inc.
NASDAQ: LXRXKey statistics
LXRX News
Stories mentioning LXRX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 21,102 | 5,493 | 14,182 | 28,866 | 1,262 | 1,550 | 1,741 | 1,617 |
| Cost of Goods Sold | 108.00 | 201.00 | 10.00 | 33.00 | 30.00 | 348.00 | 71.00 | 166.00 |
| Gross Profit | 20,994 | 5,292 | 14,172 | 28,833 | 1,232 | 1,202 | 1,670 | 1,451 |
| Operating Expenses | ||||||||
| Research & Development | 12,756 | 11,314 | 18,757 | 15,747 | 15,303 | 26,685 | 25,780 | 17,643 |
| Sales General & Admin | 9,234 | 8,759 | 7,602 | 9,350 | 11,608 | 32,258 | 39,592 | 39,192 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (996.00) | (14,781) | (12,187) | 3,736 | (25,679) | (32,737) | (63,693) | (55,354) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 1,543 | 1,283 | 1,573 | 1,834 | 2,219 | 2,829 | 3,444 | 4,136 |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (1,043) | (15,529) | (12,769) | 3,252 | (25,295) | (33,766) | (64,811) | (53,429) |
| Earnings Per Share (Basic) | 0.00 | (0.04) | (0.04) | 0.01 | (0.07) | (0.11) | (0.18) | (0.17) |
| Earnings Per Share (Diluted) | 0.00 | (0.04) | (0.04) | 0.01 | (0.07) | (0.11) | (0.18) | (0.17) |
| Weighted Average Shares Outstanding (Basic) | 400,240 | 363,053 | 363,399 | 363,294 | 362,073 | 320,031 | 361,492 | 310,836 |
| Weighted Average Shares Outstanding (Diluted) | 400,240 | 363,053 | 363,399 | 363,570 | 362,073 | 320,031 | 361,492 | 310,836 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About LXRX
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol LXRX. It last traded at $1.82 (Nov 12, 2026, 4:00 PM ET), down 2.7% on the day. That gives Lexicon Pharmaceuticals a market capitalisation of $832.6M.
Over the past 52 weeks LXRX has traded between $1.10 and $2.68.
Revenue for the quarter ended Mar 31, 2026 was $21.1M; a net loss of $1.0M. Revenue was up 1572% from $1.3M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $21.1M | -$1.0M | -4.9% |
| Dec 31, 2025 | $5.5M | -$15.5M | -282.7% |
| Sep 30, 2025 | $14.2M | -$12.8M | -90.0% |
| Jun 30, 2025 | $28.9M | $3.3M | 11.3% |
From Lexicon Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…